Przybylowski Leon, Parent John J, Herrmann Jeremy L, Kean Adam C
Department of Pediatrics, Division of Pediatric Cardiology, The Ohio State University School of Medicine, Columbus, OH, USA.
Department of Pediatrics, Division of Pediatric Cardiology, Indiana University School of Medicine, Indianapolis, IN, USA.
J Innov Card Rhythm Manag. 2025 Jul 15;16(7):6385-6390. doi: 10.19102/icrm.2025.16074. eCollection 2025 Jul.
Hypertrophic cardiomyopathy (HCM) is an inherited disease present in 1 in 500 individuals and is the most common cause of sudden cardiac death in children. We present the case of a 17-year-old boy with HCM and a primary prevention subcutaneous implantable cardioverter-defibrillator (S-ICD) who developed left ventricular outflow tract obstruction and a myocardial bridge of the left anterior descending coronary artery. The patient underwent a septal myectomy/myotomy and muscular bridge unroofing. The S-ICD system was undisturbed during the surgery, with no loss of function. Septal myectomy may be accomplished in pediatric HCM patients following optimal S-ICD placement with maintained S-ICD function.
肥厚型心肌病(HCM)是一种遗传性疾病,每500人中就有1人患病,是儿童心源性猝死的最常见原因。我们报告一例17岁患有HCM的男孩,其植入了一级预防皮下植入式心律转复除颤器(S-ICD),该患者出现了左心室流出道梗阻和左前降支冠状动脉心肌桥。患者接受了室间隔心肌切除术/肌切开术和心肌桥松解术。手术过程中S-ICD系统未受干扰,功能未丧失。在儿科HCM患者中,在最佳位置植入S-ICD并维持其功能后可进行室间隔心肌切除术。